Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LEPROT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WIPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KCNB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST8SIA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LL22NC03-63E9.3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FABP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALPPL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRRG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CADM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf64 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STARD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on